Identifying a Role for Emerging Therapies in Idiopathic Inflammatory Myopathies (IIMs)

Activity Overview

Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of rare autoimmune disorders in which diagnosis and management can be uniquely challenging, as these conditions affect multiple organ systems and often coexist with other overlapping diseases. Treatment still largely rests on traditional immunosuppression tailored to disease subtype and severity, with no standardized guidelines to guide those decisions.

In this archived video from the 2026 Carolina Neuromuscular Disease Summit, expert faculty will highlight individualized, multidisciplinary management planning for patients with IIMs. Patient cases anchor the discussion and show where the current standard of care falls short, which segues into a review of emerging clinical trial data on investigational therapies and how these strategies may fit into future treatment protocols.

Target Audience

This activity is intended for neuromuscular specialists, neurologists, nurse practitioners, physician assistants, and nurses who treat neuromuscular diseases.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Design individualized multidisciplinary management plans for IIMs and their associated comorbidities
• Review the limitations of the current treatment landscape for IIMs
• Evaluate clinical trial data for emerging therapies for IIMs

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.

This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.

The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.

This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.